Prelude Capital Management’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.47M Buy
5,495
+716
+15% +$198K 0.11% 217
2025
Q4
$1.32M Sell
4,779
-557
-10% -$156K 0.1% 228
2025
Q3
$1.54M Buy
5,336
+526
+11% +$156K 0.12% 217
2025
Q2
$1.59M Buy
+4,810
New +$1.55M 0.15% 166
2024
Q4
Sell
-4,614
Closed -$1.6M 1259
2024
Q3
$1.6M Buy
4,614
+525
+13% +$181K 0.1% 271
2024
Q2
$1.35M Buy
4,089
+689
+20% +$238K 0.09% 259
2024
Q1
$1.23M Sell
3,400
-159
-4% -$52.3K 0.06% 346
2023
Q4
$1.07M Sell
3,559
-2,410
-40% -$704K 0.07% 288
2023
Q3
$1.71M Buy
5,969
+3,054
+105% +$871K 0.11% 212
2023
Q2
$818K Buy
+2,915
New +$759K 0.05% 338
2023
Q1
Sell
-1,317
Closed -$436K 1215
2022
Q4
$436K Sell
1,317
-969
-42% -$307K 0.02% 622
2022
Q3
$634K Buy
2,286
+564
+33% +$159K 0.02% 557
2022
Q2
$454K Buy
+1,722
New +$444K 0.01% 858
2021
Q3
Sell
-2,426
Closed -$575K 1780
2021
Q2
$575K Buy
2,426
+1,321
+120% +$330K 0.02% 871
2021
Q1
$267K Sell
1,105
-507
-31% -$113K 0.01% 1199
2020
Q4
$336K Buy
+1,612
New +$316K 0.01% 871
2020
Q1
Sell
-2,155
Closed -$418K 1501
2019
Q4
$441K Buy
2,155
+1,083
+101% +$199K 0.02% 596
2019
Q3
$163K Buy
1,072
+706
+193% +$115K 0.01% 808
2019
Q2
$58K Sell
366
-1,128
-76% -$177K ﹤0.01% 1078
2019
Q1
$240K Buy
+1,494
New +$273K 0.01% 657
2018
Q2
Sell
-236
Closed -$40K 1696
2018
Q1
$40K Sell
236
-390
-62% -$75.8K ﹤0.01% 1137
2017
Q4
$127K Sell
626
-1,276
-67% -$254K 0.01% 731
2017
Q3
$356K Buy
1,902
+571
+43% +$102K 0.03% 466
2017
Q2
$223K Buy
1,331
+468
+54% +$75.2K 0.02% 540
2017
Q1
$126K Buy
+863
New +$127K 0.01% 712
2016
Q4
Sell
-424
Closed -$55K 1573
2016
Q3
$55K Sell
424
-2,620
-86% -$342K 0.01% 1012
2016
Q2
$390K Sell
3,044
-696
-19% -$91.9K 0.05% 331
2016
Q1
$513K Sell
3,740
-580
-13% -$79.6K 0.07% 303
2015
Q4
$632K Sell
4,320
-5,015
-54% -$689K 0.1% 226
2015
Q3
$1.26M Buy
9,335
+5,200
+126% +$755K 0.18% 130
2015
Q2
$670K Buy
4,135
+728
+21% +$101K 0.09% 241
2015
Q1
$441K Sell
3,407
-3,299
-49% -$383K 0.06% 382
2014
Q4
$690K Buy
6,706
+2,631
+65% +$259K 0.1% 227
2014
Q3
$370K Buy
4,075
+75
+2% +$7.01K 0.05% 483
2014
Q2
$368K Sell
4,000
-100
-2% -$8.58K 0.05% 498
2014
Q1
$343K Sell
4,100
-1,000
-20% -$82.4K 0.05% 542
2013
Q4
$446K Buy
+5,100
New +$417K 0.07% 384

Other funds holding CI

Prelude Capital Management's CI Position: Q1 2026 in Review

Prelude Capital Management increased its Cigna (CI) stake by 15% in Q1 2026, buying an estimated $198K and bringing the position to 5,495 shares worth $1.47M. The position accounts for 0.11% of the portfolio, ranked #217.

Prelude Capital Management first reported a position in CI in Q4 2013 and has held it in 37 quarters since. The position peaked at $1.71M in Q3 2023. 1,655 funds tracked by Wall St. Rank hold CI as of Q1 2026.

  • Prelude Capital Management held 5,495 shares of Cigna worth $1.47M as of Q1 2026.
  • Prelude Capital Management bought 716 Cigna shares in Q1 2026, an estimated $198K.
  • Cigna made up 0.11% of Prelude Capital Management's portfolio in Q1 2026, its #217 holding.
  • Prelude Capital Management first reported a position in Cigna in Q4 2013 and has held it in 37 quarters since.
  • Prelude Capital Management's Cigna position peaked at $1.71M in Q3 2023.
  • 1,655 funds tracked by Wall St. Rank held Cigna as of Q1 2026.

Based on Prelude Capital Management's 13F filing for Q1 2026, filed 15 May 2026.